BayesPK Generics

Market Intelligence OS
Checking platform ANDA strategy Portfolio-ready Patent-aware
Generic Market Opportunity Intelligence

Portfolio Decision OS

Prioritize generic opportunities using market size, ROI, competition, patent runway, development cost, regulatory difficulty, bioequivalence risk, launch timing, evidence confidence and stage-gate actions.

Marketsize, ROI, payback, revenue potential
Competitionplayers, crowding, launch attractiveness
Regulatoryguidance, BE risk, development difficulty
Launchpatent runway and scenario priority
Opportunity score
—
Run analysis
Market size
—
Revenue pool
ROI
—
Payback
Competition
—
Crowding risk
Regulatory clarity
—
Guidance / BE
Launch feasibility
—
Patent runway

Boardroom Recommendation

Plain-English recommendation for management decision.
not analyzed
Run Analyze Opportunity to generate a product decision.

Next Best Actions

What the team should do next.
actionable

Strategic Fit

Should this molecule enter the pipeline?

Key Risks

Commercial, legal, regulatory and technical risk.

Investment View

Cost, payback and upside.

Commercial Opportunity

Market size, revenue potential, ROI and payback.

Competition & Crowding

Competitor intensity and price pressure logic.

Top Opportunities

Fast shortlist for portfolio review.

Regulatory Pathway

Guidance clarity, BE burden and development complexity.

Bioequivalence Risk

Expected study probability and formulation burden.

Patent & Exclusivity View

Patent runway, filing posture and launch feasibility.

Launch Timing

Wait, challenge, partner, design-around or avoid.

Scenario Builder

Risk-adjusted strategy choices.

Decision Matrix

Build / wait / challenge / partner / drop.

Portfolio Ranking

Prioritize multiple generic opportunities.

Product Comparison

Compare molecules side by side.

Development Playbook

Actions by team and stage.

Evidence Confidence

Source confidence and missing evidence.

Management Report

Plain-English investment memo.

Product Differentiators

Why this becomes a market-standard tool.
BayesPK Generics Market Intelligence is a decision-support platform. Confirm market assumptions, patents, regulatory guidance, BE design and CMC feasibility before investment.
`; const blob=new Blob([html],{type:"text/html"});const url=URL.createObjectURL(blob);const a=document.createElement("a");a.href=url;a.download=`bayespk_market_intelligence_${d}_${new Date().toISOString().slice(0,10)}.html`;a.click();URL.revokeObjectURL(url);toast("Report downloaded."); } function loadSample(name){ setInputValue("molecule",name); if(name==="semaglutide"){setInputValue("compareMolecule","empagliflozin");setInputValue("cvInput",35);setInputValue("trInput",.94);setInputValue("salesInput",21000);setInputValue("genericInput",0);setInputValue("costInput",26)} toast(`Loaded ${name} sample.`); } async function loadProducts(){try{const data=await get(API.products);const products=$("#products");if(products)products.innerHTML=(data.products||[]).map(p=>`